J Breast Cancer.
2006 Jun;9(2):74-83. 10.4048/jbc.2006.9.2.74.
Validation and Controversy of Sentinel Node Biopsy for Breast Cancer
- Affiliations
-
- 1Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan. motomurak@hotmail.com
- 2Department of Pathology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
- 3Department of Cytology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
- KMID: 2286623
- DOI: http://doi.org/10.4048/jbc.2006.9.2.74
Abstract
- Sentinel node biopsy has become a promising technique to accurately stage breast cancer patients with less morbidity than axillary lymph node dissection. However, many problems remain, such as the ideal injection technique, agents, and histological detection of sentinel node metastases, and they must be addressed before sentinel node biopsy becomes the standard for the care of breast cancer patients. The results of ongoing large clinical trials will provide clues to solve these problems. The purpose of this article is to review the current literature regarding confirmation of the sentinel node hypothesis and the controversy of sentinel node biopsy.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Number of Removed Lymph Nodes for an Acceptable False Negative Rate in Sentinel Lymph Node Biopsy for Breast Cancer
- Sentinel Lymph Node Biopsy in Breast Cancer: A Clinical Review and Update
- Profound Hypotension after an Intradermal Injection of Indigo Carmine for Sentinel Node Mapping
- Minimally Invasive Surgery Based on Sentinel Node Biopsy for Gastrointestinal Cancer
- Optimized Criteria for Sentinel Lymph Node Biopsy in Patients with Clinically Node Negative Breast Cancer
